Abstract: Glutamate (GLU) and -aminobutyric acid (GABA) are important amino acid neurotransmitters that, respectively, mediate rapid excitatory and inhibitory neurotransmission in the brain. Serum GLU and GABA levels could play a significant role in pathogenesis of the encephalopathic state, early detection of autism, and the neurobiology of depression. The optimal concentration ratio of GLU and GABA is vital for neuroendocrine control, and deviations in their synthesis are linked to epilepsy. Additionally, circulating GLU affects GABA levels in striatal extracellular fluid. The present work explores the feasibility of employing surface-enhanced Raman scattering spectroscopy, in conjunction with partial least squares (PLS), for simultaneous measurement of physiological concentrations of GLU and GABA in their aqueous solution and blood serum. A PLS calibration model showed a high coefficient of determination ðR 2 > 0:98Þ between the spectral data of GLU and GABA and their respective concentrations. The low root mean square error of prediction (RMSEP) value was È2.7 M, and it established the accuracy of the calibration model. The present methodology enabled the detection of GLU and GABA as low as 8 M. This provides a cost-effective alternative to existing techniques for quantification of neurotransmitters.
Introduction
nanoparticles were an obvious choice for our study as Raman signals of small molecules like GLU and GABA are easily amplified by these nanoparticles.
GLU, GABA, hydroxylamine hydrochloride, sodium hydroxide, and silver nitrate were purchased from Sigma Aldrich, and blood samples were obtained from a local bovine slaughter house. Ultra filtered serum (UFS) was prepared by centrifuging the blood at 4000 r/min for 20 minutes. The colloidal silver nanoparticles (AgNP) were prepared according to the method described by Leopold et al. [37] , that is, a 4.5 mL of sodium hydroxide solution (0.1 M) was added to 5 mL of hydroxylamine hydrochloride solution (0.06 M). The role of hydroxylamine hydrochloride was to reduce silver nitrate while sodium hydroxide controlled the size and dispersion of AgNP. The mixture was added rapidly to 90 mL of silver nitrate solution (0.001 M) and shaken for a few seconds, which produced a milky-gray colored solution. The UV-vis absorption/ extinction spectra and TEM images of 2 different batches of AgNP are shown in Fig. 1 . The UV-vis absorption spectra of two batches of AgNP are quite similar with minimal shift in the absorbance peak as shown in Fig. 1 . It further suggests that the size/shape of nanoparticles from one synthesis to other are similar and reproducible with limited clustering/aggregation. Moreover, all the spectral measurements were performed under identical experimental condition to achieve good quality and reproducible spectra.
The sample mixtures of GLU and GABA were divided into three groups. The first and second groups consisted of different sample mixtures of GLU-GABA in DI water, and the third group was GLU-GABA in blood serum. The first group of samples was comprised of eight sample mixtures of GLU, GABA and nanoparticles in DI water in the millimolar range. The concentration of GLU in four of these samples was constant while the concentration of GABA varied, and the concentration of GABA in the remaining four samples was constant while the concentration of GLU varied. These eight different samples were prepared, as shown in Table 1 . The second group of samples consisted of five mixtures of GLU-GABA in DI water in the micromolar range, as shown in Table 2 . The third group of samples were prepared exactly the same way as the second group, but using cow serum. The third group consisted of serum of five cows (A, B, C, D, and E). Five sets of sample solution of GLU and GABA were prepared in serum where each set contained serum that belonged to different cows. The samples in each of these sets were labelled as A1-A5, B1-B5, C1-C5, D1-D5, and E1-E5, respectively. In all three groups of samples, 400 L of prepared AgNP was added to 800 L of mixture of GLU and GABA.
SERS Experimental Configuration
The experimental configuration included a 785-nm continuous wavelength multimode laser (B&W Tek Inc., Newark, DE, USA) with a maximum output power of 450 mW. The laser beam was first collimated by a plano-convex lens and passed through a bandpass filter centered at 785 nm (T2 nm) to filter out other wavelength components around 785 nm from the laser. It was then directed through a dichroic filter (R785RDC, Chroma Technologies Corp., VT, USA) that reflected 785 nm (T5 nm) at an angle of 45 degrees and transmitted light in the 790 to 1000 nm range. The dichroic filter acted as a reflector for the laser beam, which was further focused on the sample in a quartz-cuvette using a 10Â microscopic objective lens (04 OAS 010, CVI Melles Griot, NY, USA) with numerical aperture (N.A.) of È0.25. The dichroic filter also acted as a highpass filter of the light scattered backward from the sample, thereby allowing only the Raman wavelengths through. The filtered Raman light was then imaged onto a fiber bundle (30 multimode fiber, N.A. ¼ 0:22, Fiberoptic System Inc., CA, USA), using another 6.3Â microscopic objective lens with N.A. of È0.20. The diameters of the core and cladding were 100 and 125 microns, respectively. The fiber bundle consisted of 30 identical fibers, with a packing efficiency of 80Q. The output of the fiber bundle was interfaced with a Kaiser f/18i Spectrograph (Kaiser Optical Systems, Inc., MI, USA) and a thermoelectrically cooled Andor charge-coupled device camera. The spectral resolution of the spectrometer was 2.05 cm j1 . Andor SOLIS software was used for spectral data acquisition, and the spectra were monitored on the data acquisition computer. The laser beam power at the sample was 250 mW, and the acquisition time for recording a spectrum was 20 s. The optical configuration described above was the optimal way to achieve Raman signals of samples with high signal-to-noise ratios.
Multivariate Data Analysis
Serum contains numerous biological components that create a strong spectral (fluorescence) background, including albumin, glycoproteins, immunoglobulins and lipoproteins. Due to the similar molecular structures of GLU and GABA, the majority of their SERS bands overlap and, consequently, no direct relationship between the GLU and GABA concentrations and their SERS bands could be determined. In these circumstances, SERS spectral data sets of GLU-GABA mixtures were used to construct two calibration models for conducting the PLS analysis with Unscrambler X version 10.0 (CAMO, Corvallis, OR, USA). PLS as a statistical method for data processing, provides a calibration model by perceiving the influence of X-variable on the variation within the Y-variable. The PLS calibration model are generated by projecting the X-variable (spectral wavelength) and Y-variable (analytical data) to a new space of so-called principal components (PCs). The first PC is defined as the direction of the most variations in Y-variable, the second PC, which is orthogonal to the first PC, is defined as the direction of the second most variance (that not described by the first PC) and so on. In the new transformed space, each observation is called "score" which is connected to the observation value (in X-Y variables space) by "loading". The main advantage of PLS is that it can produce the calibration model even if the number of independent variable (X-variable) is more than number of experimental observations. It also can provide models for more than one dependent variables simultaneously, i.e., GLU and GABA in this work.
Prior to the PLS regression of GLU-GABA data set, the spectra were background subtracted by Unscrambler software to remove the fluorescence effect. Raman spectral data were normalized using multiple scattering correction (MSC) to correct the variability of the baseline data, which is caused by scattering or other physical phenomena. The calibration model was validated by either a test set validation (TSV) or a full cross validation (FCV) method. The construction of an efficient PLS model required careful selection of a number of principal components (PCs). The optimal number of PCs are used for constructing the calibration model with low root mean square error of prediction (RMSEP) values, thus resulting in accurate prediction of samples (GLU and GABA).The PLS model is most commonly evaluated against various statistical parameters, including root mean square error of calibration (RMSEC), root mean square error of prediction (RMSEP) and coefficient of determination (R 2 ). Moreover, the evaluation of generated PLS models of GLU-GABA data set was empowered by calculating the p-value and repeatability parameters, which made this study distinct from similar works [30] , [38] , [39] .
Results and Discussion

GLU-GABA Mixture in DI Water
Raman Spectral Data
First, the SERS spectra of GLU and GABA mixtures in de-ionized (DI) water were recorded. The main purpose of this was to identify the unique SERS peaks of GLU and GABA. Since water is a simple matrix compared to serum, well-resolved peaks corresponding to GLU and GABA were obtained, as there was practically no interference of Raman water peaks with those of GLU or GABA. For group 1, eight different mixtures of GLU, GABA and nanoparticles in the millimolar range were prepared (Table 1) , and the amount of nanoparticles in all eight samples was 400 L. The SERS spectra of these mixtures of GABA and GLU are shown in Fig. 2 . A spectral range of 500 to 1600 cm j1 was used in this analysis. Fig. 2 shows the SERS spectra of eight sets of sample mixtures with relatively different concentrations of GLU and GABA. According to Fig. 2 , SERS peaks at 832 cm j1 (due to the contribution of deformation modes of C-O and N-H), 907 cm (completely ionized form of GLU, stretching mode of C-COO -band), 1036 cm j1 (C-N, CH 2 bands) and 1386 cm j1 (corresponded to the symmetrical stretching of the COO -group) are common SERS peaks of GLU and GABA [23] , [24] , [40] - [42] . Fig. 2 shows the SERS spectra of aqueous mixtures of GLU and GABA with relatively different concentration ratios. The figure also indicates that SERS peak intensity of GLU varies significantly compared to that of GABA, with respective variation of their amounts in the sample mixtures. This can be attributed to the fact that the GLU molecule has one more carboxylic group than GABA, resulting in higher Raman modes of vibration. It should be noted that prominent SERS peaks near 832 cm j1 and 858 cm j1 are unique to GLU and GABA, respectively, and these can distinguish one from the other.
There was good correspondence between the SERS bands of GLU and GABA in DI water in the millimolar range and in their concentrations. As a result, the evaluation of this linear association can be done using a simple calibration model, as V. Tiwari et al. reported [26] . The second group of samples consisted of five mixtures of GLU-GABA in DI water in the micromolar range, as seen in Table 2 . For such a concentration, a more precise calibration based on the PLS model was applied.
Loading and Score Plots
Loading plots can be considered the bridge between variable space and the principal component space, and provide a projection view of the inter-variable relationship. Loading plot has more important role in determining the contribution of different peaks when low concentrations of analyte causes the Raman spectra of samples to be indistinguishable. In this case, loading plot could be more informative than Raman spectra of samples. In simple terms, they indicate the individual contribution of each variable (wavenumbers in our case) to each PC. The loading of the first and second PC are shown in Fig. 3(a) , are due to GABA [23] , [24] , [40] - [42] . Consequently, the wavenumbers 684, 807, 832, 874, 893, 954, 993, 1093, 1162, 1186, 1235, 1255, 1295, 1356, and 1441 cm j1 can discriminate between GLU and GABA in the mixture. The regression coefficients plot is another feature that can highlight important wavenumbers in this analysis. However, it is not shown here because it is similar to the loading plot; hence, it provides no new information.
Like loading vectors, score vectors can also be plotted against each other. These plots are complementary in nature, and provide significant information about the objects and variables when studied together. The score plot is based on distribution of samples in PC space. This plot is used to interpret the structure of observations. The plotting of any score vectors against each other could help us to reveal the hidden structure of spectra [29] . Thus, score plots indicate any clustering of variables, or the presence of outliers that need to be eliminated. The score plot of PC1 and PC2 is shown in Fig. 3(b) . These first two plots show that 85Q (X1 71Q, X2 14Q) of the X variance explains 91Q (Y1 67Q, Y2 24Q) of response mixture concentration. This figure discloses highly distinguishable clusters in the samples, which means that most of the samples in each cluster are similar, and different concentrations are distributed in different clusters. Loading and score plots have significant relevance in this work.
PLS Model
The SERS spectra of five samples of GLU-GABA mixtures in DI water were recorded. For each sample, 20 Raman spectra were collected to ensure consistency of the replicated measurements; thus, the total number of Raman spectra was 100. The PLS model was developed by using two thirds of the data set as a calibration set for constructing the model, and using the remaining one third as a validation set for model evaluation. Approximately 15Q of recorded spectra were identified as outliers by the Unscrambler software and removed accordingly from the analysis. According to this model, the R 2 (for calibration and validation) RMSEC, and RMSEP for the spectral range of 500 to 1600 cm j1 are 0.99, 0.99, 1.2, and 1.4. All calculations are based on the TSV model by using six PCs, which reduced the RMSEP value compared to the FCV model, which is not shown here. The result of predictions by the TSV model are summarized in Table 3 , and they indicate that the PLS model with the TSV validation method can reliably predict different concentrations of GLU-GABA in DI water, with deviation in the range of 0.9 to 1.3 M. The deviation is an estimated uncertainty of each sample prediction based on constructed calibration model which was calculated by the Unscrambler software.
GLU-GABA Mixture in Serum
SERS Spectral Data
The ultimate goal of our study was to simultaneously measure the clinical-level concentration of GLU and GABA in serum by SERS spectroscopy. The role of nanoparticles in enhancing the weak Raman signal is important to determine the detection limit of GLU and GABA. It is worth mentioning here that the signal enhancement factor calculated in this study takes into account only the ratio of enhanced Raman peak intensity and normal Raman peak intensity. It does not consider the ratio of number of molecules sampled in bulk and those which are adsorbed on the nanoparticles surface, usually represented in evaluating the Raman enhancement factor (also termed as G factor). SERS peaks of GLU (0.1M) in serum and GABA (0.1M) in serum were compared with Raman peaks of those solutions (not shown here). The Raman signal enhancement factor of AgNP was around 10. Fig. 4 shows SERS spectrum of different concentration of pure GLU in serum and pure GABA in serum. The SERS intensity of GLU-GABA mixture in serum decreases compare to their SERS intensities in DI water as shown in Fig. 5 . This is attributed to the fact that the optical activity of nanoparticles was affected when the sampling matrix was changed from water to serum, resulting in reduction of the Raman signal enhancing ability of nanoparticles. Further, it should be noted that some of discriminative wavenumbers in water and serum, i.e. the peak at 1003 cm j1 (see Fig. 5 ) and the peak at 1005 cm j1 [see Fig. 6 (a)] have appeared due to the complexity of serum compared to water. However, these peaks are low intensity and do not interfere with SERS bands of GLU and GABA. This is attributed to the fact that ultra-filtered serum was used in the experiment which contained lower concentrations of biological components. Also, partial least squares (PLS) analysis only observes systematic variation in the spectral range that result due to increase or decrease of SERS peaks of GLU or GABA corresponding to their sample concentration. Consequently, correlating the Raman bands of GLU and GABA with their concentrations by formulating a simple calibration model was virtually impossible. Hence, PLS models were constructed based on the Raman spectra of GLU and GABA in serum mixtures. The loadings of the GLU-GABA mixture in serum of the first and fourth PC are shown in Fig. 6(a) show only GLU contribution in the mixture [23] , [24] , [40] - [42] . In addition, the peaks at 710 cm j1 and 737 cm j1 are due to the presence of either nanoparticles, protein or carbohydrate in the serum [43] . Moreover, the loadings of GLU-GABA mixture in serum of the fifth and sixth PC (not shown here) have a peak at 807 cm j1 , which is assigned to the GABA in the mixture.
Consequently, the wavenumbers 553, 807, 832, 954, 968, 993, 1093, 1162, 1186, 1235, 1255, 1271, 1295, 1356, and 1441 cm j1 are discriminative for the GLU-GABA mixture in serum. It should be noted that some of discriminative wavenumbers in water and serum are different, due to the complexity of serum compared to water.
Similar to the DI water mixture, score plot provides information about the relation between different sets of the A, B, D and E samples (set C was set aside for independent prediction). The score plot of PC1 and PC2 is shown in Fig. 6(b) . The first two PCs indicate that 99Q (X1 98Q, X2 1Q) of the X variance explains 71Q (Y1 3Q, Y2 68Q) of the response mixture concentration. The percentage of response mixture concentration in serum (71Q) is less than in water (91Q), due to the complexity of serum. Although the clustering in the samples was not as clear as in the DI water case, Fig. 6(b) shows that the clusters of serum samples A and B are still distinguishable while serum samples D are very close to samples E.
PLS Model
There were five groups of samples (A, B, C, D, and E) where each of this group was characterized with different serum. Each group consisted of five samples of GLU and GABA of relatively different concentration ratios. Thus, the total number of samples were 25 (5 Ã 5).The Raman spectra of 25 samples of GLU and GABA mixture in serum were recorded. To ensure consistency in the replicated measurements, 20 Raman spectra were collected for each sample. Thus, the total number of Raman spectra was 500.
The PLS model was constructed using four sample sets of serum, while the fifth sample was set aside for making independent prediction. For example, Model 1 was developed using the data sets of A, B, C, and D, Model 2 was developed using the data sets of A, B, C, and E, and so on. Approximately 9Q of recorded spectra were identified as outliers by the Unscrambler software and removed accordingly from the analysis. Table 4 shows the R 2 , RMSEC, and RMSEP results of each of the five possible PLS models, for the spectral range of 500 to 1600 cm j1 . The models were validated based on the TSV method, which has lower prediction error than the FCV method when the sample set is large enough. 
TABLE 4
Five possible PLS models of GLU-GABA mixture in serum with TSV
The PLS model obtained from preprocessed data involved five or six PCs. The optimal number of PCs was established by evaluating Y-variable residuals versus PC numbers (not shown here) and determining the values of PCs with residual variance tending toward zero. The number of PCs was optimized to reduce RMSEP values, as indicated in Table 4 . All five possible models showed high R 2 (Q 0.98) and low RMSEP (ranges from 2.5-2.8 M). The average RMSEP value for these five PLS models is 2.7 M, and the standard deviation of these variations is 0.11. The higher errors for RMSEC and RMSEP in serum compared to water were predictable, due to the lower percentage of response in serum compared to water. Regardless, the ability of this model to recognise the discriminative wavenumbers enabled us to accurately predict the different concentrations. The prediction result of the PLS model is shown in Fig. 7 , and the calibration curve indicates the measured and predicted value of GLU and GABA in the mixture. The model was based on pre-processed data, and validated with the TSV method. According to the calibration curve, the RMSEP error in TSV (within the range of 10 to 90 M) is approximately 2.5 M, which corresponds to È3Q. The overall conclusion is that amounts of GLU and GABA as low as È8 M can be detected with error as low as 2.7 M, as required in a clinical environment. 
Repeatability of Measurements
The spectra of groups A, B, C, and D were recorded in the first day and the spectra of group E were recorded in the second day. The average SERS intensity of groups A, B, C, and D were compared with the SERS intensity of group E by looking at one of SERS peak of related spectra. For example at 934 cm j1 , the average of SERS intensities of all recorded spectra of samples L1 (GABAC10 M þ GLUC90 M) of groups A, B, C, and D were calculated, and then, it was compared with that intensity of samples L1 of group E. The p-values, the number that explains the chance of a true difference between groups of samples, and repeatability were calculated from Analysis of Variance (ANOVA) by using MS Excel. The p-value and repeatability of samples L1 to samples L5 are listed in Table 5 . The p-value less than 0.05 refers to high repeatable measurement. The repeatability of these samples were between 0.69 and 0.89 which means that SERS intensities of identical concentrations of GLU and GABA in different serum (sample matrix) solutions, i.e., A to E were highly repeatable (Q 0.7). Fig. 8 demonstrates the spectra of 20 raw spectra of sample L1 in DI water and serum and shows the reproducibility of recorded data and also compares the spectrum of samples in DI water and serum samples.
Predicting GLU and GABA Concentrations in Unknown Sample
The third group of samples in serum was evaluated by external validation. PLS Model 3, which was comprised of sample sets A, B, D, and E, was evaluated by predicting a set of unknown serum samples (sample set C). The model was validated against the sample set data (C), which was set aside during model construction. It predicted different concentrations of GLU and GABA in serum, in the range of 10 to 90 M. The result, which is summarized in Table 6, shows   TABLE 5 Repeatability of SERS intensity of different groups at wavenumber 934 cm Our standard procedure was to take 20 spectra of each sample and apply PLS to predict the sample concentration with certain accuracy. However, to further establish the prediction accuracy, another procedure was used as follows: we have averaged the spectral data points of all the samples of particular concentration (samples L1) from all the group (A, B, C, D, and E). The similar procedure of averaging of data points corresponding to samples of other concentrations (samples, L2, L3, L4, and L5) from each group (A, B, C, D, and E) was carried out.
The PLS model of averaged spectral data points of sample corresponding to groups A, B, D, and E was constructed. It was validated against the averaged sample set data C, which was set aside during model construction. According to these models for GLU and GABA, RMSEP was 2.2 M for GLU model and 2.0 M for GABA model which were in the range of previous results. The constructed models predicted different concentrations of GLU and GABA in serum, and the result is summarized in Table 7 . The deviations of predictions were between 1.3 M and 1.8 M which show the accuracy of PLS models for averaged spectral data points of samples.
The detection limit of SERS for both GLU and GABA was approximately 8 M, which is higher than the detection limit of methods such as LC-MS/MS and HPLC, which is in the nM range. However, the in-house instrumentation for our study used lower cost optics than techniques currently being employed for monitoring GLU and GABA. Moreover, our method does not require intricate sampling procedures and causes no sample degradation, as demonstrated by the similarity in the spectrum of the samples collected on various days. The method of monitoring GLU and GABA, as presented here, could be further improved if the process of spectral data acquisition and subsequent feeding into the pre-built calibrated model was fully automated. There is also interest in developing new nanoparticle synthesis protocols that enhance the GLU and GABA Raman signals in complex body fluids. In brief, the SERS/PLS-based method of detecting GLU and GABA, as described here, could potentially become a viable clinical tool for the quantitative measurement of GLU and GABA in clinical environments.
Conclusion
We have established that SERS, in conjunction with PLS, can be used to simultaneously monitor the concentration of GLU and GABA in serum. The characteristic SERS bands of GLU and GABA were used to distinguish GLU and GABA in serum. Based on PLS analysis, the constructed calibration model showed a high coefficient of regression (R 2 È0.98), and a low value of root mean square error of prediction (RMSEP È2.7 M). Our results indicate that the PLS regression model can measure concentrations of both GLU and GABA in serum È8 M range, as required in clinical environments. Our proposed method employed a simple, low-cost experimental configuration that accurately measured the concentrations of GLU and GABA. Hence, it has the potential to be considered as a viable alternative to some of the existing techniques for monitoring GLU and GABA in clinical environments. Future work will focus on determining the concentrations of GLU-GABA in whole blood.
